Stocks in Action: Evotec, Fraport, ING Groep, Sartorius, Nordex
Reading Time: 4 minutes
Stock 1.) Evotec - Drug developer benefits from increasing R&D expenditure, Berenberg starts with Buy and sees price target of €10 (Upside potential: 68%) One of the most important Buy ratings comes on Tuesday from Berenberg Bank for Evotec. The coverage was started with "Buy" and a price target of €10. Analysts pointed to Evotec's strong market position, providing extensive solutions in drug research and development to its clients. The valuation of Evotec leaves a lot of room, even with a mere normalization of demand, the analysts added....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
